Brief: Sensorion Announces Results Of New Sens-401 Preclinical Data

Sensorion SA

07/11/2019 07:00

Nov 7 (Reuters) - SENSORION SA  ALSEN.PA :
    * SENSORION ANNOUNCES AN ORAL PRESENTATION OF NEW SENS-401
PRECLINICAL DATA AT ISIET 2019 IN HANNOVER
    * RESULTS SUGGEST THAT SENS-401, IN ADDITION TO ABILITY TO
PRESERVE SENSORY CELLS AND HEARING FUNCTION PERIPHERALLY IN
COCHLEA, COULD ALSO REDUCE LOSS OF CENTRAL AUDITORY NEURONS IN
SENSORINEURAL HEARING LOSS PATHOLOGIES
    * SENS-401: COULD CONFER ADDITIONAL CLINICAL TREATMENT
BENEFITS
SUCH AS REDUCED INCIDENCE/SEVERITY OF TINNITUS OR CENTRAL
AUDITORY PROCESSING DEFICITS FOR PATIENTS

Source text for Eikon:  ID:nBw6CHw5ca 
Further company coverage:  ALSEN.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48587785110;))